Supernus Pharmaceuticals (NASDAQ:SUPN) PT Lowered to $42.00
Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) had its target price trimmed by Piper Sandler from $43.00 to $42.00 in a report published on Wednesday, Benzinga reports. The firm currently has an overweight rating on the specialty pharmaceutical company’s stock. Separately, StockNews.com upgraded shares of Supernus Pharmaceuticals from a hold rating to a buy rating in […]
More Stories
Covestro (ETR:1COV) Stock Price Up 0.1% – What’s Next?
Covestro AG (ETR:1COV – Get Free Report) shares traded up 0.1% on Monday . The company traded as high as...
Neptune Wellness Solutions (TSE:NEPT) Shares Down 3.4% – Here’s What Happened
Neptune Wellness Solutions Inc. (TSE:NEPT – Get Free Report) shares traded down 3.4% during mid-day trading on Monday . The...
CPI Card Group (TSE:PMTS) Stock Price Down 1.5% – Here’s What Happened
Shares of CPI Card Group Inc. (TSE:PMTS – Get Free Report) (NASDAQ:PMTS) traded down 1.5% on Monday . The stock...
NGEx Resources (TSE:NGQ) Trading 5.7% Higher – Here’s Why
NGEx Resources Inc (TSE:NGQ – Get Free Report)’s stock price rose 5.7% during trading on Monday . The stock traded...
Thor Explorations (CVE:THX) Trading Down 1.8% – Time to Sell?
Thor Explorations Ltd. (CVE:THX – Get Free Report) fell 1.8% during mid-day trading on Monday . The stock traded as...
Surge Energy (OTCMKTS:ZPTAF) Stock Price Down 1.1% – Should You Sell?
Surge Energy Inc. (OTCMKTS:ZPTAF – Get Free Report)’s stock price fell 1.1% during mid-day trading on Monday . The stock...